cambridge bioscience cbcx start aid test cambridge bioscience receive federal drug administration approval investigational drug file begin human clinical trial generation diagnostic aid company anticipate release worldwide market cambridge bioscience expect file soon investigational drug fda screen detect aid antibody evaluate emergency situation african nation require highly train technician instrumentation accord company cambridge bioscience explain file human clinical trial aid receive fda approval utilize recombinantdna technology detect screen antibody blood serum patient infect aidscausing virus separate plan file fda revolutionary fiveminute latex agglutination screen detect aid antibody company utilize latex bead coat cbc recombinant antigen attract hold aid antibody form cluster agglutination indicate positive result 
